Analysts want Merck to consider a merger

12/12/2003 | Bloomberg Businessweek

Analysts are worried Merck's independent strategy is slowing growth, despite the company's announcement about some hopeful early-stage drugs. This month's annual meeting did spark a glimmer of hope for analysts, however, as some said there seemed to be an increasing willingness on the company's part to at least consider mergers.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care